GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Regentis Biomaterials Ltd. RGNT · USD

US listing · 🇺🇸 United States

Compare

1.27

+6.72%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Regentis Biomaterials Ltd. — daily RGNT Delayed
Market value
$6.6m
Last close × shares
Volume
221.1k
Shares, 9 Nov 2026

About Regentis Biomaterials Ltd.

Its shares trade under the ticker RGNT. It has been listed since 4 December 2025.

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Figures and description from our data supplier, not checked against the company's own report.

More about Regentis Biomaterials Ltd. →

Latest on Regentis Biomaterials Ltd.

Our reporting

We have not reported on Regentis Biomaterials Ltd. yet.

Other United States listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Regentis Biomaterials Ltd.'s ticker?

Regentis Biomaterials Ltd. trades as RGNT on its US listing, under ISIN IL0012190968.

What was Regentis Biomaterials Ltd.'s last closing price?

1.27 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.